Concepedia

Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah’s Witness experience

James N. George, Steven Sandler, Joanna Stankiewicz

Blood Advances · 2017 · 30 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

TTP in Jehovah's Witness patients has been managed successfully without PEX.This experience, plus new TTP treatments, may make it possible for patients who are not Jehovah's Witnesses to avoid PEX in the future.

References

14

Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura

G. Rock, Kenneth H. Shumak, N Buskard et al. · New England Journal of Medicine · 1991 · 1.9K citations · Full text

, , +8

Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga et al. · New England Journal of Medicine · 2016 · 658 citations · Full text

, , +17

Survival and relapse in patients with thrombotic thrombocytopenic purpura

Johanna A. Kremer Hovinga, Sara K. Vesely, Deirdra R. Terrell et al. · Blood · 2009 · 570 citations · Full text

, , +8

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

Marie Scully, Vickie McDonald, Jamie Cavenagh et al. · Blood · 2011 · 423 citations · Full text

, , +5

Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors

Elizabeth A. Sekul · Annals of Internal Medicine · 1994 · 365 citations

, , +11